Long; Shinong
Patent Applications and Registrations
Patent applications and USPTO patent grants for Long; Shinong.The latest application filed is for "targeted therapeutic lysosomal enzyme fusion proteins and uses thereof".
- Long; Shinong - Novato CA
- Long; Shinong - San Ramon CA
- Long; Shinong - Milpitas CA US
| Patent | Date |
|---|---|
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20220127326 - Aoyagi-Scharber; Mika ; et al. | 2022-04-28 |
| Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 11,254,725 - Aoyagi-Scharber , et al. February 22, 2 | 2022-02-22 |
| Variants of C-type natriuretic peptide Grant RE48,267 - Wendt , et al. October 20, 2 | 2020-10-20 |
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20190225666 - Aoyagi-Scharber; Mika ; et al. | 2019-07-25 |
| Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins Grant 10,301,369 - Aoyagi-Scharber , et al. | 2019-05-28 |
| Variants of C-type natriuretic peptide Grant RE46,707 - Wendt , et al. February 13, 2 | 2018-02-13 |
| Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,845,346 - Aoyagi-Scharber , et al. December 19, 2 | 2017-12-19 |
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20170355744 - AOYAGI-SCHARBER; MIKA ; et al. | 2017-12-14 |
| Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,834,587 - Aoyagi-Scharber , et al. December 5, 2 | 2017-12-05 |
| Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,834,588 - Aoyagi-Scharber , et al. December 5, 2 | 2017-12-05 |
| Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,771,408 - Aoyagi-Scharber , et al. September 26, 2 | 2017-09-26 |
| Variants of C-Type Natriuretic Peptide App 20170051033 - Wendt; Daniel J. ; et al. | 2017-02-23 |
| Variants of C-Type Natriuretic Peptide App 20160256553 - Wendt; Daniel J. ; et al. | 2016-09-08 |
| Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,376,480 - Aoyagi-Scharber , et al. June 28, 2 | 2016-06-28 |
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160039900 - Aoyagi-Scharber; Mika ; et al. | 2016-02-11 |
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160031965 - Aoyagi-Scharber; Mika ; et al. | 2016-02-04 |
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160031963 - Aoyagi-Scharber; Mika ; et al. | 2016-02-04 |
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160031964 - Aoyagi-Scharber; Mika ; et al. | 2016-02-04 |
| Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20140161788 - Aoyagi-Scharber; Mika ; et al. | 2014-06-12 |
| Variants of C-type natriuretic peptide Grant 8,598,121 - Wendt , et al. December 3, 2 | 2013-12-03 |
| Variants of C-type Natriuretic Peptide App 20120316114 - Wendt; Daniel J. ; et al. | 2012-12-13 |
| Variants of C-type natriuretic peptide Grant 8,198,242 - Wendt , et al. June 12, 2 | 2012-06-12 |
| Variants of C-Type Natriuretic Peptide App 20100297021 - Wendt; Daniel J. ; et al. | 2010-11-25 |
| Methods Of Enhancing Yield Of Active Iga Protease App 20100261252 - Long; Shinong ; et al. | 2010-10-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 